MarketPeel
Insider Trading Intelligence
Pricing
…
BQ

Barry D. Quart

HRTX
CHIEF EXECUTIVE OFFICER · HERON THERAPEUTICS, INC. /DE/ · CIK 0001384243
FILING MIX · LIFETIME50%/50%
BUYS
53
SELLS
52
TOTAL VALUE
$5.03M
COMPANIES
2
ACTIVE SINCE
Jun 2015
HOLDINGS NOW
862,185
AVG SELL PX
$29.34
TRADE KIND
SHOWING 105 / 105
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 28 pending
Forward-return performance of every backtestable P/S trade by Barry D. Quart, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+58.33%-0.83%+0.43%-1.25%-0.72%—
14d12+66.67%-1.59%+1.12%-2.71%-2.69%—
30d12+50.00%+0.93%+0.96%+0.23%+3.55%—
60d12+16.67%+5.43%+1.88%+3.55%+4.37%—
90d12(2 pending)+10.00%+21.04%+5.19%+15.85%+19.26%—
180d12(7 pending)+20.00%+24.62%+11.50%+13.12%+23.05%—
1y12(8 pending)+25.00%+46.75%+20.74%+26.02%+40.03%—
2y12(11 pending)+0.00%+38.72%+55.98%-17.26%-17.26%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
HRTX · 850,000 shares · as of Jan 18, 2023
0212,500425,000637,500850,00020162017201820192020202120222023SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2015
2015
2015
2016
2016
2016
2016
2017
2017
2017
2017
2018
2018
2018
2018
2019
2019
2019
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 53 buys / 52 sellsCOVERAGE · 45 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
12,158——12,185May 29, 2026Jun 2, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
2,799——0May 29, 2026Jun 2, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
2,799——15,345May 29, 2026Jun 2, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
2,026——2,026May 29, 2026Jun 2, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
13,099——13,237Apr 28, 2026Apr 29, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE10b5-1
10b5-1 plan
13,099$50.10$656.3K12,546Apr 28, 2026Apr 29, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
13,099$14.33$187.7K25,645Apr 28, 2026Apr 29, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE10b5-1
10b5-1 plan
6,901$50.00$345.1K12,546Apr 6, 2026Apr 8, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
6,901$14.33$98.9K19,447Apr 6, 2026Apr 8, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
6,901——26,336Apr 6, 2026Apr 8, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
2,690——0Feb 12, 2026Feb 12, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE10b5-1
10b5-1 plan
2,690$45.00$121.0K12,546Feb 12, 2026Feb 12, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
2,690$15.47$41.6K15,236Feb 12, 2026Feb 12, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE10b5-1
10b5-1 plan
110$45.00$5.0K12,546Feb 10, 2026Feb 12, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
110$15.47$1.7K12,656Feb 10, 2026Feb 12, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
110——2,690Feb 10, 2026Feb 12, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE10b5-1
10b5-1 plan
2,602$45.02$117.1K12,546Feb 4, 2026Feb 4, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
2,602——2,800Feb 4, 2026Feb 4, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
2,602$15.47$40.3K15,148Feb 4, 2026Feb 4, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
12,528——5,402Feb 3, 2026Feb 4, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE10b5-1
10b5-1 plan
12,528$45.27$567.1K12,546Feb 3, 2026Feb 4, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
12,528$15.47$193.8K25,074Feb 3, 2026Feb 4, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE10b5-1
10b5-1 plan
830$45.00$37.4K12,546Feb 2, 2026Feb 4, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
830——17,930Feb 2, 2026Feb 4, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
830$15.47$12.8K13,376Feb 2, 2026Feb 4, 2026 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE10b5-1
10b5-1 plan
20,129$41.51$835.6K12,546Dec 15, 2025Dec 17, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
20,129$10.36$208.5K32,675Dec 15, 2025Dec 17, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
20,129——0Dec 15, 2025Dec 17, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
12,336$30.39$374.9K12,546Jun 11, 2025Jun 11, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
12,336——0Jun 11, 2025Jun 11, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
12,336$3.80$46.9K24,882Jun 11, 2025Jun 11, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
8,212$3.80$31.2K20,758Jun 10, 2025Jun 11, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
8,212$30.36$249.3K12,546Jun 10, 2025Jun 11, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
8,212——12,336Jun 10, 2025Jun 11, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
6,900$3.80$26.2K19,446Jun 9, 2025Jun 11, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
6,900$30.26$208.8K12,546Jun 9, 2025Jun 11, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
6,900——20,548Jun 9, 2025Jun 11, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
3,173——0Jun 5, 2025Jun 5, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
3,173——12,546Jun 5, 2025Jun 5, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
2,799——2,799Jun 3, 2025Jun 5, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
16,798——16,798Jun 3, 2025Jun 5, 2025 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
4,373——0Jun 6, 2024Jun 7, 2024 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
4,373——9,373Jun 6, 2024Jun 7, 2024 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
19,040——19,040Jun 5, 2024Jun 7, 2024 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
3,173——3,173Jun 5, 2024Jun 7, 2024 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
5,000——5,000Jun 29, 2023Jul 3, 2023 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
5,000——0Jun 29, 2023Jul 3, 2023 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
4,373——4,373Jun 6, 2023Jun 8, 2023 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
26,236——26,236Jun 6, 2023Jun 8, 2023 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
850,000——850,000Jan 18, 2023Jan 20, 2023 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
5,219$3.17$16.5K177,989Jan 13, 2023Jan 17, 2023 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
16,122——183,208Jan 13, 2023Jan 17, 2023 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
3,645——25,521Jan 13, 2023Jan 17, 2023 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
3,645——167,086Jan 13, 2023Jan 17, 2023 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
16,122——114,807Jan 13, 2023Jan 17, 2023 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASE
21,959$1.59$34.9K21,959Nov 29, 2022Dec 1, 2022 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
21,959——0Nov 29, 2022Dec 1, 2022 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SALE
21,959$16.15$354.6K0Nov 29, 2022Dec 1, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
1,655$3.27$5.4K163,441Oct 31, 2022Jan 17, 2023 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
3,646——150,883Oct 13, 2022Oct 17, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
16,122——167,005Oct 13, 2022Oct 17, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
5,219$3.76$19.6K161,786Oct 13, 2022Oct 17, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
3,646——29,166Oct 13, 2022Oct 17, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
16,122——130,929Oct 13, 2022Oct 17, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
3,646——32,812Jul 13, 2022Jul 15, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
16,122——147,051Jul 13, 2022Jul 15, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
16,122——152,456Jul 13, 2022Jul 15, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
3,646——136,334Jul 13, 2022Jul 15, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
5,219$3.01$15.7K147,237Jul 13, 2022Jul 15, 2022 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
30,000——30,000Jun 29, 2022Jun 30, 2022 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
5,000——5,000Jun 29, 2022Jun 30, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
1,504$3.84$5.8K132,688Apr 29, 2022Jul 15, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
5,219$6.07$31.7K131,184Apr 13, 2022Apr 15, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
3,646——120,281Apr 13, 2022Apr 15, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
3,646——36,458Apr 13, 2022Apr 15, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
16,122——163,173Apr 13, 2022Apr 15, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
16,122——136,403Apr 13, 2022Apr 15, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
16,122——179,295Jan 13, 2022Jan 14, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
3,646——105,732Jan 13, 2022Jan 14, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
3,646——40,104Jan 13, 2022Jan 14, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
16,122——121,854Jan 13, 2022Jan 14, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
5,219$8.30$43.3K116,635Jan 13, 2022Jan 14, 2022 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
3,646——103,049Oct 13, 2021Oct 15, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
390,834——390,834Oct 13, 2021Oct 15, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
3,646——43,750Oct 13, 2021Oct 15, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
195,417——195,417Oct 13, 2021Oct 15, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
963$10.55$10.2K102,086Oct 13, 2021Oct 15, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
963$13.48$13.0K99,403Jul 13, 2021Jul 15, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
3,645——47,396Jul 13, 2021Jul 15, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
3,645——100,366Jul 13, 2021Jul 15, 2021 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
33,237——33,237Jun 29, 2021Jun 30, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
1,529$13.90$21.2K96,721Apr 30, 2021Jul 15, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
3,646——51,041Apr 13, 2021Apr 15, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
3,646——96,155Apr 13, 2021Apr 15, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
963$16.66$16.0K95,192Apr 13, 2021Apr 15, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
3,646——92,872Jan 13, 2021Jan 15, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
963$18.16$17.5K91,909Jan 13, 2021Jan 15, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALE
Chief Executive Officer
3,646——54,687Jan 13, 2021Jan 15, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
350,000——350,000Oct 13, 2020Oct 15, 2020 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
58,333——58,333Oct 13, 2020Oct 15, 2020 ↗View →
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
PURCHASEGRANT
Stock grant
18,760——18,760Jun 30, 2020Jul 2, 2020 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
1,158$12.12$14.0K89,226Apr 30, 2020Oct 15, 2020 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Gift
600——92,509Nov 4, 2016Apr 15, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
SALEGRANT
Gift
600——0Nov 4, 2016Apr 15, 2021 ↗View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
Chief Executive Officer
600——600Jun 20, 2015Apr 15, 2021 ↗View →
Other insiders · HRTX
Loading peer insiders…
About this filer
CIK 0001384243
ROLE
Chief Executive Officer
PRIMARY
HRTX
COMPANIES
2
ACTIVE SINCE
Jun 2015
MARKETPEEL · /INSIDER/0001384243DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback